Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

roche_close

Death in trial of Roche’s potential blockbuster haemophilia drug

February 24, 2017 Medical Communications, Research and Development Novo Nordisk, Roche, Shire, haemophilia

Roche has reported a death in the trial of its haemophilia treatment, emicizumab, that will only add to safety concerns …
News
cognition_kit

Takeda collaborates to launch wearable-tech depression study

February 23, 2017 Medical Communications, Research and Development Takeda, depression, mental health, wearable tech

Takeda and Cognition Kit Limited have announced a collaborative venture to trial the use of an app in the monitoring …
News
2000px-bristol-myers_squibb_logo

BMS temporarily expands Board with three new additions

February 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb

Bristol-Myers Squibb has bolstered its Board of Directors with the appointment of three Directors, a move which temporarily expands its …
Appointment
pfizer_brussels

Pfizer’s Remicade biosimilar displays similar efficacy

February 22, 2017 Research and Development Johnson & Johnson, Pfizer, Remicade, inflectra

Pfizer and Celltrion have announced new data for their Remicade biosimilar, Inflectra, that shows that the drug is comparable in …
News

Insider Interview: BGMA Director Warwick Smith disputes recent generic price increase claims

February 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Warwick Smith, bgma, generics

Warwick Smith, Director of the British Generic Manufacturer’s Association (BGMA), discusses the recent data suggesting generic drug prices in the …
Feature
roche__tree

Roche and Discuva extend agreement to develop target antimicrobials

February 22, 2017 Research and Development, Sales and Marketing Discuva, Roche

Discuva, a drug discovery company based in Cambridge, UK, has announced that its collaboration with Roche, first agreed in 2014, …
News
8224204466_e6b23e80e6_z

Rabbit virus proves effective in treatment of multiple myeloma

February 22, 2017 Research and Development multiple myeloma

A team of researchers at the Medical University of South Carolina (MUSC) utilising the myxoma virus (MYXV) to treat multiple …
News
old_man_stick

Testosterone gel trials reveal mixed results of benefits and drawbacks

February 22, 2017 Research and Development Testosterone gel, testosterone

A large study looking into the potential positive or negative effects of supplementing older men with testosterone gel revealed definitive …
News
headshot_ryan

Nativis bolsters boardroom with new director

February 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nativis

Nativis Inc., a clinical stage life science bio-electronic company, has announced the appointment of Dr Una Ryan to its board …
Appointment
pharmafocus_march_cover

The March 2017 issue of Pharmafocus is now live!

February 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, FDA, Johnson & Johnson, MSD, Roche, Trump, crispr, immunotherapy, opdivo

The latest edition of Pharmafocus is available to read online now! From breakthroughs in antibiotic resistance R&D to gene editing …
News

FDA Priority Review for Pfizer investigational leukaemia drug

February 22, 2017 Research and Development, Sales and Marketing EMA, FDA, Inotuzumab ozogamicin, Pfizer, priority review

Pfizer has announced that its leukaemia treatment inotuzumab ozogamicin has been accepted for Priority Review by the US Food and …
News
naloxone

FDA rejects Amphastar’s application for NDA for intranasal overdose treatment

February 21, 2017 Research and Development Amphastar, FDA

Amphastar has received a Complete Response Letter (CRL) for its New Drug Application (NDA) for an intranasal version of Naloxone, …
News
aging_-_hand

Anti-aging study reveals role of mitochondria pointing towards new medicine

February 21, 2017 Manufacturing and Production, Research and Development Anti-aging, SkQ1, anti aging, mitochondria

A joint study between researchers from Russia and Sweden has revealed the extent to which mitochondria play a role in …
News

BlackThorn Therapeutics bring in new CEO

February 20, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BlackThorn Therapeutics

BlackThorn Therapeutics, a biopharmaceutical company that works on developing treatments for neurobehavioral disorders, announced the appointment of Gregory Vontz to …
Appointment
celgene_1_02

Celgene’s potential blockbuster gets positive Phase 3 results in multiple sclerosis

February 20, 2017 Research and Development, Sales and Marketing Celgene, multiple sclerosis

Celgene’s drug to treat patients suffering with relapsing multiple sclerosis (RMS) was given a boost by positive Phase 3 trial …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025